Monday, November 2, 2020

This is the ONE:TSX-V That Can Double or Triple On This News - PWC has 285,000 Employees and Multi Billion Dollar Clients

01 Communique Signs a Co-operation agreement with PwC to Implement Quantum-Safe IronCAP Cryptography Technology

 

TORONTO, ON – November 2, 2020. 01 Communique Laboratory Inc. (“01 Communique”) (TSX-V: ONE; OTCQB: OONEF) today announced it has entered into a joint business relationship with PwC, one of the world’s leading professional services firm, to bring post-quantum cryptography technology and its related services to enterprise customers.

 

Our collaboration comes at a time when cyber security is on every organization’s top agenda and those who look beyond 




 




House Positions for C:ONE from 20201103 to 20201103
HouseBought$ValAveSold$ValAveNet$Net
88 Credential30,00012,9000.43030,000-12,900
33 Canaccord21,0008,8470.421021,000-8,847
2 RBC18,0007,7300.4292,0008300.41516,000-6,900
79 CIBC15,0006,4500.43015,000-6,450
9 BMO Nesbitt8,0753,4720.4308,075-3,472
85 Scotia2,0008600.4302,000-860
53 Morgan Stanley1,5006250.417100420.421,400-583
124 Questrade1,1504830.4201,150-483
68 Leede100420.42150630.42-5021
74 GMP02,0008600.43-2,000860
143 Pershing02,0008500.425-2,000850
92 Pollitt02,0008400.42-2,000840
13 Instinet014,0006,0200.43-14,0006,020
80 National Bank020,0008,3050.415-20,0008,305
7 TD Sec10,5004,4150.4230,57512,9970.425-20,0758,582
1 Anonymous83,00035,0450.422117,50050,0620.426-34,50015,017
TOTAL190,32580,8690.425190,32580,8690.42500


Insiders exercised options at .05 cents and have been selling into the market in this rally from the news




Company Stock Issues - 01 COMMUNIQUE LABORATORY INC
Symbol
Name
ONE
01 COMMUNIQUE LABORATORY INC
Fundamental Data - ONE
Security TypeEquity
Shares Issued91,393,973
Market Cap31,988,000
Year High0.46
Year Low0.07
Sector45101010 - Internet Software & Services

 There are 3256 shares short - Oct 15 2020 out of  91,393,973 Shares


Short Positions for ONE
SymbolReport DateVolumeChangeShares Issued% Float
V : ONE2020-10-153,2563,25691,393,9730.00
V : ONE2020-09-1528,075-42,16390,577,3060.03
V : ONE2020-08-3170,238-47,86285,502,3060.08
V : ONE2020-08-15118,10062,46682,677,3060.14
V : ONE2020-07-3155,63455,63481,918,8060.07
V : ONE2020-06-302,0002,00081,918,8060.00
V : ONE2020-05-15282-18,01780,235,4720.00
V : ONE2020-04-3018,299-24,70180,235,4720.02
V : ONE2020-04-1543,00043,00080,235,4720.05
V : ONE2020-03-1510,000-34,50080,235,4720.01
V : ONE2020-02-2944,500-46,50080,235,4720.06
V : ONE2020-02-1591,00091,00080,235,4720.11
V : ONE2019-11-3057,92757,92780,235,4720.07
V : ONE2019-10-31277-7,31080,235,4720.00
V : ONE2019-10-157,5877,58780,235,4720.01
V : ONE2019-08-3110,46310,12080,185,4720.01
V : ONE2019-08-15343-4,65780,185,4720.00
V : ONE2019-07-315,00079880,185,4720.01
V : ONE2019-07-154,2022,42176,543,8070.01
V : ONE2019-06-301,7811,78176,543,8070.00
V : ONE2019-05-313,000-13,80076,543,8070.00
V : ONE2019-05-1516,800-46,20076,543,8070.02
V : ONE2019-04-3063,00063,00076,543,8070.08
V : ONE2019-03-3121,30021,30076,543,8070.03
V : ONE2019-02-155,7205,72076,543,8070.01
V : ONE2018-09-300-10,00076,543,8070.00
V : ONE2018-09-1510,00010,00076,543,8070.01
V : ONE2018-08-310-27,00066,543,8070.00
V : ONE2018-08-1527,00016,90066,543,8070.04
V : ONE2018-07-3110,10010,10066,543,8070.02
V : ONE2018-07-150-1,00066,543,8070.00
V : ONE2018-06-301,000-31,00066,543,8070.00
V : ONE2018-06-1532,00017,00066,543,8070.05
V : ONE2018-05-3115,0009,90066,543,8070.02
V : ONE2018-05-155,1005,10066,543,8070.01
V : ONE2018-03-150-1,00066,543,8070.00
V : ONE2018-02-281,0001,00066,543,8070.00
V : ONE2018-02-150-20066,543,8070.00
V : ONE2018-01-31200066,543,8070.00
V : ONE2018-01-1520020066,543,8070.00
V : ONE2016-10-150-36,00066,543,8070.00
V : ONE2016-09-3036,00036,00066,543,8070.

 


01 Communique 
Signs a Co-operation agreement with PwC to Implement Quantum-Safe IronCAP Cryptography Technology

 

TORONTO, ON – November 2, 2020. 01 Communique Laboratory Inc. (“01 Communique”) (TSX-V: ONE; OTCQB: OONEF) today announced it has entered into a joint business relationship with PwC, one of the world’s leading professional services firm, to bring post-quantum cryptography technology and its related services to enterprise customers.

 

Our collaboration comes at a time when cyber security is on every organization’s top agenda and those who look beyond today’s challenges are proactively preparing for the looming threat brought by the advent of quantum computers. The “new norm” means that it is mission critical to protect the whole eco-system from cyber-attacks not just for today, but more importantly to prepare for tomorrow’s even more powerful quantum attacks. 01 Communique’s cryptographic technology, IronCAP, operates on classical computer systems to protect your platforms today and in the world of quantum computers.

 

In July 2020, PwC’s latest SMB survey responded by over 1,000 IT decision makers across Asia Pacific only 27% of small and medium-sized businesses (SMB) have a dedicated cybersecurity team whereas 57% of them experienced an online attack in the last 24 months. Viruses and malware (51%), web-based attacks (38%) and phishing attacks (32%) were identified as the top-three cyberattacks on SMBs. PwC along with IronCAP, the best in class quantum-safe encryption combined with an end-to-end solution, offer a brand-new option for executives to better prepare for the future.

 

William Gee, Partner, Digitalization Office, PwC China stated, “We are in the early days of a totally new technology, quantum computing; one that truly disrupts many of the principles that we know today.  PwC is proud to enter this joint business relationship.  We are positioning for the coming of a new age of computing, one that brings new possibilities and have far greater transformational and disruptive powers that we have seen with today’s classical computers.”

 

Samuel Sinn, Cybersecurity and Privacy Partner of PwC China added, “The technology development in computing is striving for speed. We are now experiencing the arrival of quantum computers - the 5th generation of computer (from vacuum tubes, transistors, integrated circuits, microprocessors to quantum computers), which has the fastest computing speed that we’ve ever seen. This will disrupt the classical encryption. In the past, it would take over a century to break an encryption, a time-consuming process even for modern classical computers. However, new types of computers are currently being developed that leverage the computational power of quantum physics. Quantum computers can reduce the time for password generation and data decryption to several hours or even minutes.  This will render the classical encryption, which we are still using today, to be obsolete.” 

 

Andrew Cheung, CEO of 01 Communique, stated, “We are very excited to partner with PwC to protect the cyberspace with our IronCAP quantum-safe cryptographic technology against cyber-attacks from classical computers and the future world of quantum computing. The time cannot be better to implement our IronCAP platform as there is great world-wide concern about the protection of personal and company data that can be collected, shared, and maliciously hacked.” IronCAP is ready to provide a bulletproof shield for your data.

 

PwC and 01 Communique Laboratory Inc. are pleased to invite our media partners, stakeholders and customers to attend our upcoming joint business relationship announcement event, details to be announced in due course. Both parties will discuss the critical mission of protecting the eco-system from cyber-attacks today and in the future world of quantum computing.

 

About PwC - Globally  

 

At PwC, our purpose is to build trust in society and solve important problems. We are a network of firms in 157 countries with more than 284,000 people who are committed to delivering quality in assurance, advisory and tax services. Find out more and tell us what matters to you by visiting us at www.pwc.com.

 

PwC refers to the PwC network and/or one or more of its member firms, each of which is a separate legal entity. Please see www.pwc.com/structure for further details.

 

 

About IronCAP and IronCAP X:

 

IronCAP is a patent-pending cryptographic system that protects users and enterprises against cyber security attacks today as well as in the future with the introduction of powerful quantum computers. Based on improved Goppa code-based encryption, it is faster and more secure than current standards. It is ready for installation now to protect your platform today with the huge benefit of added security against attacks from the world of quantum computers. Our flagship product, IronCAP API, allows vendors to easily apply IronCAP technology to a wide variety of vertical applications making them quantum-safe.

 

Recently launched, IronCAP X, is the world’s first quantum-safe cybersecurity product for email/file encryption. IronCAP X adopts the best in class end-to-end encryption approach by delivering each encrypted message directly to recipients ensuring only the intended persons can decrypt and read the message. This approach by-passes the centralised email server which has become an easy target for cyber-attacks. Furthermore, our digital signature feature ensures the recipient and the sender are verified thus eliminating the chance of a phishing scam. Those adopting IronCAP X will enjoy the best of both worlds: end-to-end email encryption delivery straight into your in-boxes with quantum-safe protection.

 

About 01 Communique

 

Established in 1992, 01 Communique (TSX-V: ONE; OTCQB: OONEF) has always been at the forefront of technology. The Company’s cyber security business unit focuses on post-quantum cybersecurity with the development of its IronCAP technology. IronCAP’s patent-pending cryptographic system is an advanced Goppa code-based post-quantum cryptographic technology that can be implemented on classical computer systems as we know them today while at the same time can also safeguard against attacks in the future post-quantum world of computing.

 

Cautionary Note Regarding Forward-looking Statements.

 

Certain statements in this news release may constitute “forward-looking” statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. When used in this news release, such statements use such words as “may”, “will”, “expect”, “believe”, “plan”, “intend”, “are confident” and other similar terminology. Such statements include statements regarding the timing of the release of IronCAP X and the future of quantum computers and their impact on the Company's product offering, the functionality of the Company's products and the intended product lines for the Company's technology. These statements reflect current expectations regarding future events and operating performance and speak only as of the date of this news release. Forward-looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to differ materially from the results discussed in the forward-looking statements, including, but not limited to, the factors discussed under “Risk and Uncertainties” in the Company’s Management`s Discussion and Analysis document filed on SEDAR. Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release, and the Company assumes no obligation to update or revise them to reflect new events or circumstances.

 

       

Neither TSX Venture Exchange (“TSX-V”) nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

 

INVESTOR CONTACT:

Brian Stringer

01 Communique

(905) 795-2888 x 204

investorrelations@01com.com



Recent Bulletins News ReleasesIn The NewsOther

Date ET Symbol Price Type Headline

2020-11-02 10:14 C:ONE 0.35 News Release 01 Communique to provide cryptography tech with PwC

2020-10-19 09:14 C:ONE 0.395 News Release 01 Communique to begin trading on OTCQB today

2020-10-15 09:28 C:ONE 0.375 News Release 01 Communique closes $400,000 debt settlement

2020-10-14 18:11 C:ONE 0.385 Shares for Debt 01 Communique 350,000 shares for debt

2020-10-07 09:30 C:ONE 0.425 News Release 01 Communique arranges $5M equity facility

2020-10-05 17:36 C:ONE 0.315 Shares for Debt 01 Communique 416,667 shares for debt

2020-10-05 16:27 C:ONE 0.315 News Release 01 Communique to settle remaining $200,000 of debenture

Thursday, June 25, 2020

APLI Technicals Ready To Run Up...Just News Needed


Add caption
House Positions for C:APLI from 20200625 to 20200625
HouseBought$ValAveSold$ValAveNet$Net
68 Leede15,00015,1501.01015,000-15,150
7 TD Sec14,23014,0930.99014,230-14,093
2 RBC11,00011,0451.004011,000-11,045
79 CIBC7,0007,0301.00407,000-7,030
9 BMO Nesbitt3,5003,4650.995005151.033,000-2,950
84 Ind Trading5004950.990500-495
80 National Bank35351.00035-35
33 Canaccord6,0005,7800.9636,0006,0751.0130295
59 PI01351351.00-135135
13 Instinet01,0001,0201.02-1,0001,020
124 Questrade08,6308,4230.976-8,6308,423
1 Anonymous15,50015,4200.99529,50029,4300.998-14,00014,010
89 Raymond James027,00026,9150.997-27,00026,915
TOTAL72,76572,5130.99772,76572,5130.99700

Short Positions



















    
    

APLI.v Accumulate at these levels this will explode with Phase 3 Approvals next 6-12mths

Company well-capitalized, reporting record level of capital support with over $27M CAN in equity financings
Pipeline portfolio strengthened with initiation of unique COVID-19 clinical study focused on preventing disease outbreaks in long-term care settings, acquisition of Phase 2-ready novel anti-fungal program, and commercialization deal for later-stage antibiotic
HALIFAX, Nova Scotia — Appili Therapeutics Inc. (TSXV: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today reported its financial and operational results for the year ended March 31, 2020.
“2020 proved to be a transformative year for Appili,” said Armand Balboni, MD, PhD, Chief Executive Officer of Appili Therapeutics. “Appili emerged fully onto the global biotech stage this year, transitioning to a publicly traded company, adding novel anti-fungal and anti-viral programs to our development portfolio, including our recently announced trial assessing favipiravir, which we believe has the potential to address a critical global unmet need as a preventative agent for COVID-19. We look forward to making continued, purposeful progress over the course of the next year as Company advances its mission to identify and address significant unmet needs in the infectious disease sector, and beyond.”
2020 and recent highlights included:
  • Financial
    • Debuted as a public company on the TSXV exchange and subsequently began trading on the OTCQX trading platform
    • Completed successful equity financings for $10.25M CAD in February 2020 and $16.9M CAD in June 2020
    • Increased its non-dilutive funding, including a $3M USD grant from the U.S. Department of Defense and a $476,000 CAD repayable contribution through Atlantic Canada Opportunities Agency
  • Leadership
    • Named Dr. Armand Balboni as new Chief Executive Officer
    • Expanded the Board of Directors with the addition of veteran biotech executive Dr. Juergen Froehlich
    • Named infectious disease specialist Dr. Yoav Golan as Appili’s Chief Medical Officer
  • Development Programs
    • Received Health Canada approval to initiate Phase 2 trial evaluating FujiFilm Toyama Chemical’s (“FFTC”) favipiravir as a prophylaxis against COVID-19 outbreaks in long-term care homes (May 2020)
    • Entered into a commercialization agreement with Saptalis Pharmaceuticals for Appili’s reformulation of the antibiotic metronidazole (December 2019)
    • Acquired ATI-2307, a novel broad spectrum anti-fungal drug candidate from FFTC to target resistant fungal infections, including Cryptococcus and Candida (November 2019)
“Appili has laid the groundwork for continued progress and impact in our industry,” said Kimberly Stephens, CPA, CA, Chief Financial Officer at Appili. “With continued support from the investor community – including two successful fundraises – and our listing on TSXV and the OTCQX trading platform, we remain well capitalized and well positioned to advance our pipeline through milestones that create value for our shareholders and solutions for patients.”
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 coronavirus) at this time.
Financial Results
The Company prepares its financial statements in accordance with IFRS as issued by the International Accounting Standard Board and Part I of Chartered Professional Accountants of Canada Handbook –Accounting. All dollar figures are $CAN unless otherwise noted.
The net loss and comprehensive loss of $5,416,496 or $0.16 loss per share for the year ended March 31, 2020 was $1,085,512 higher than the net loss and comprehensive loss of $4,330,984 or $0.14 loss per share during the year ended March 31, 2019. This relates mainly to a $909,918 increase in general and administrative expenses, a $1,483,478 decrease in government assistance and a $80,949 increase in business development, offset by a $1,242,315 decrease in research and development (R&D) expenses and a $53,588 increase in accreted interest.


https://business.financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/appili-therapeutics-announces-fy-2020-annual-and-financial-results